Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
-
* Corresponding author: Manfred Herold manfred.herold@uibk.ac.at
Arthritis Research & Therapy 2006, 8:R119 doi:10.1186/ar2008
Accesses
- Last 30 days: 65 accesses
- Last year: 847 accesses
- All time: 5886 accesses
Cited by
BioMed Central: 4 citations
|
Research article
Diego Catalán, Octavio Aravena, Francisca Sabugo, Pamela Wurmann, Lilian Soto, Alexis M Kalergis, Miguel Cuchacovich, Juan C Aguillón, Arthritis Research & Therapy 2010, 12:R68 (15 April 2010) |
|
Review
The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis Ger JM Pruijn, Allan Wiik, Walther J van Venrooij Arthritis Research & Therapy 2010, 12:203 (15 February 2010) |
|
Research article
Pascale Nicaise Roland, Sabine Grootenboer Mignot, Alessandra Bruns, Margarita Hurtado, Elisabeth Palazzo, Gilles Hayem, Philippe Dieudé, Olivier Meyer, Sylvie Chollet Martin Arthritis Research & Therapy 2008, 10:R142 (10 December 2008) Antibodies to mutated citrullinated vimentin complement the use of anti-cyclic citrullinated peptides antibodies in the diagnosis of rheumatoid arthritis, and may be useful for monitoring infliximab therapy.
|
|
Research article
Jennie Ursum, Markus MJ Nielen, Dirkjan van Schaardenburg, Ann R van der Horst, Rob J van de Stadt, Ben AC Dijkmans, Dörte Hamann Arthritis Research & Therapy 2008, 10:R12 (28 January 2008) |